Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Insiders Selling Foot Locker, Dave And This Drug Giant's Stock

Published 30/09/2022, 13:58
Updated 30/09/2022, 14:40
© Reuters Insiders Selling Foot Locker, Dave And This Drug Giant's Stock

The Nasdaq Composite dropped by over 300 points on Thursday. Investors, meanwhile, focused on some notable insider trades.

When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to go short on the stock. Insider sales should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a selling decision.

Below is a look at a few recent notable insider sales. For more, check out Benzinga's insider transactions platform.

Foot Locker (NYSE:FL)

  • The Trade: Foot Locker, Inc. (NYSE: FL) 10% owner Daniel Kretinsky sold a total of 308,663 shares at an average price of $34.87. The insider received around $10.76 million from selling those shares.
  • What’s Happening: Foot Locker, last month, reported Q2 results and announced a CEO transition.
  • What Foot Locker Does: Foot Locker Inc operates thousands of retail stores throughout the United States, Canada, Europe, Australia, and New Zealand.
Nike NKE Target TGT

Eli Lilly and Company (NYSE:LLY)

  • The Trade: Eli Lilly and Company (NYSE: LLY) 10% owner Lilly Endowment Inc sold a total of 101,631 shares at an average price of $335.07. The insider received around $34.05 million as a result of the transaction.
  • What’s Happening: The U.S. Equal Employment Opportunity Commission (EEOC) recently accused Eli Lilly of illegally refusing to hire older workers for sales representative jobs because of their age.
  • What Eli Lilly Does: Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Dave

  • The Trade: Dave Inc. (NASDAQ: DAVE) 10% owner William Maris sold a total of 748,120 shares at an average price of $0.38. The insider received around $287.01 thousand from selling those shares.
  • What’s Happening: Dave, last month, reported worse-than-expected Q2 sales results.
  • What Dave Does: Dave Inc is engaged in offering banking app that offers its customers banking, financial insights, overdraft protection, building credit, and finding side gigs.

Read the original article on Benzinga

Latest comments

Its a good idea😌
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.